Related Experiment Video
Updated: Oct 1, 2025

A Murine Model of Group B Streptococcus Vaginal Colonization
Published on: November 16, 2016
Toward the development of a protein-based group B Streptococcus vaccine
Kristen Dominguez1, Tara M Randis1,2
1Department of Molecular Medicine, University of South Florida; Morsani School of Medicine.
Abstract:
Clinical trials of protein-based vaccines to prevent Group B streptococcal infections are underway. In this issue of Cell Reports Medicine, Pawlowski et al.1 provide an extensive characterization of the immune response generated by the recently tested GBS-NN vaccine.
More Related Videos
13:53Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes
Published on: December 19, 2020
13:47Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
Published on: May 19, 2020
Related Concept Videos
Microorganisms in Medicine and Therapeutics
Vaccinations